Rosales, Nilda .

HRN: 25-05-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/06/2024
11/13/2024
IV
300 MG
Q6H
INFECTED WOUND
Waiting Final Action 
11/06/2024
CEFTRIAXONE 1G (VIAL)
11/06/2024
11/13/2024
IV
2G
Q24HRS
INFECTED WOUND
Waiting Final Action 
11/09/2024
MUPIROCIN 2%, 15G (TUBE)
11/09/2024
11/16/2024
TOPICAL
2%
Bid
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: